These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36061128)

  • 1. An
    Fathi J; Nazarian S; Kordbacheh E; Hadi N
    Avicenna J Med Biotechnol; 2022; 14(3):247-258. PubMed ID: 36061128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigate the immunogenic and protective effect of trivalent chimeric protein containing IpaD-StxB-TolC antigens as a vaccine candidate against S. dysenteri and S. flexneri.
    Fathi J; Amani J; Nazarian S; Hadi N; Mirhosseini SA; Ranjbar R; Abianeh HS
    Microb Pathog; 2023 May; 178():106066. PubMed ID: 36924900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenic Potency of a Chimeric Protein Comprising InvH and IpaD against Salmonella and Shigella spp.
    Emami Mahmoudabadi FS; Vakili A; Nazarian S; Amani J; Mousavi Gargari SL
    Iran J Allergy Asthma Immunol; 2021 Aug; 20(4):484-493. PubMed ID: 34418902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An approach to chimeric subunit immunogen provides efficient protection against toxicity, type III and type v secretion systems of Shigella.
    Felegary A; Nazarian S; Kordbacheh E; Fathi J; Minae ME
    Int Immunopharmacol; 2021 Nov; 100():108132. PubMed ID: 34508943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing of a chimeric protein contains StxB, intimin and EscC against toxicity and adherence of enterohemorrhagic Escherichia coli O157:H7 and evaluation of serum antibody titers against it.
    Sadri Najafabadi Z; Nazarian S; Kargar M; Kafilzadeh F
    Mol Immunol; 2021 Jun; 134():218-227. PubMed ID: 33823320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing and Analyzing the Structure of DT-STXB Fusion Protein as an Anti-tumor Agent: An
    Mohseni Moghadam Z; Halabian R; Sedighian H; Behzadi E; Amani J; Imani Fooladi AA
    Iran J Pathol; 2019; 14(4):305-312. PubMed ID: 31754360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Silico designing and immunogenic production of the multimeric CfaB*ST, CfaE, LTB antigen as a peptide vaccine against Enterotoxigenic Escherichia coli.
    Asmani F; Khavari-Nejad RA; Salmanian AH; Amani J
    Microb Pathog; 2021 Sep; 158():105087. PubMed ID: 34256098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico design of a novel chimeric shigella IpaB fused to C terminal of clostridium perfringens enterotoxin as a vaccine candidate.
    Arabshahi S; Nayeri Fasaei B; Derakhshandeh A; Novinrooz A
    Bioengineered; 2018 Jan; 9(1):170-177. PubMed ID: 29091543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-silico design and production of a novel antigenic chimeric Shigella IpaB fused to C-terminal of Clostridium perfringens enterotoxin.
    Arabshahi S; Derakhshandeh A; Nayeri Fasaei B; Novinrooz A
    Mol Biol Rep; 2019 Dec; 46(6):6105-6115. PubMed ID: 31473892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico Analysis, Molecular Docking, Molecular Dynamic, Cloning, Expression and Purification of Chimeric Protein in Colorectal Cancer Treatment.
    Dana H; Mahmoodi Chalbatani G; Gharagouzloo E; Miri SR; Memari F; Rasoolzadeh R; Zinatizadeh MR; Kheirandish Zarandi P; Marmari V
    Drug Des Devel Ther; 2020; 14():309-329. PubMed ID: 32158188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent in vitro antitumor activity of B-subunit of Shiga toxin conjugated to the diphtheria toxin against breast cancer.
    Mohseni Z; Sedighian H; Halabian R; Amani J; Behzadi E; Imani Fooladi AA
    Eur J Pharmacol; 2021 May; 899():174057. PubMed ID: 33753109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing a multi-epitope vaccine for cross-protection against Shigella spp: An immunoinformatics and structural vaccinology study.
    Nosrati M; Hajizade A; Nazarian S; Amani J; Namvar Vansofla A; Tarverdizadeh Y
    Mol Immunol; 2019 Dec; 116():106-116. PubMed ID: 31634814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-silico design, expression, and purification of novel chimeric Escherichia coli O157:H7 OmpA fused to LTB protein in Escherichia coli.
    Novinrooz A; Zahraei Salehi T; Firouzi R; Arabshahi S; Derakhshandeh A
    PLoS One; 2017; 12(3):e0173761. PubMed ID: 28296951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico design of a vaccine candidate based on autotransporters and HSP against the causal agent of shigellosis, Shigella flexneri.
    León Y; Zapata L; Salas-Burgos A; Oñate A
    Mol Immunol; 2020 May; 121():47-58. PubMed ID: 32163758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IpaD-loaded N-trimethyl Chitosan Nanoparticles Can Efficiently Protect Guinea Pigs against Shigella flexneri.
    Akbari MR; Saadati M; Honari H; Ghorbani HM
    Iran J Immunol; 2019 Sep; 16(3):212-224. PubMed ID: 31552830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine.
    Martinez-Becerra FJ; Chen X; Dickenson NE; Choudhari SP; Harrison K; Clements JD; Picking WD; Van De Verg LL; Walker RI; Picking WL
    Infect Immun; 2013 Dec; 81(12):4470-7. PubMed ID: 24060976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing and evaluation of an antibody-targeted chimeric recombinant vaccine encoding Shigella flexneri outer membrane antigens.
    Kazi A; Hisyam Ismail CMK; Anthony AA; Chuah C; Leow CH; Lim BH; Banga Singh KK; Leow CY
    Infect Genet Evol; 2020 Jun; 80():104176. PubMed ID: 31923724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression, purification, characterization, and cytotoxic evaluation of the ML1-STxB fusion protein.
    Yousefi MH; Afkhami H; Akbari A; Honari H
    Arch Microbiol; 2023 May; 205(6):220. PubMed ID: 37148384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes.
    Heine SJ; Diaz-McNair J; Andar AU; Drachenberg CB; van de Verg L; Walker R; Picking WL; Pasetti MF
    J Immunol; 2014 Feb; 192(4):1630-40. PubMed ID: 24453241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of epitope and surface-exposed domains of Shigella flexneri invasion plasmid antigen D (IpaD).
    Turbyfill KR; Mertz JA; Mallett CP; Oaks EV
    Infect Immun; 1998 May; 66(5):1999-2006. PubMed ID: 9573082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.